Xenia Sango
Company: VivaZome Therapeutics
Job title: Chief Executive Officer & Managing Director
Seminars:
Chair’s Opening Remarks 8:50 am
day: Conference Day Two
Roundtable Discussion: into Market Conditions for Exosome/EV Therapy Development 1:00 pm
Understanding how market conditions can influence investor interest and funding availability for exosome and EV therapy development Demonstrating clinical promise and addressing regulatory hurdles to mitigate investor concerns and maintain confidence in exosome and EV-based therapies Exploring the potential for new innovations in exosome and EV development to attract investment in exosome therapy developmentRead more
day: Conference Day Two